Are the side effects of Eltrombopag/Eltrombopag serious for girls?

Eltrombopag/Eltrombopag is an oral drug used to treat thrombocytopenia, especially in idiopathic thrombocytopenia (ITP) and thrombocytopenia associated with certain liver diseases. However, female patients may experience some specific side effects when using eltrombopag, and the severity of these side effects varies between individuals.

Eltrombopag may cause liver function abnormalities, and female patients need to pay special attention to the monitoring of liver function during treatment. Studies have shown that some patients may experience elevated liver enzymes after taking this drug, which is of particular concern for patients taking it for a long time. Doctors often recommend regular liver function tests so that problems can be detected early and treatment can be adjusted in a timely manner. If liver function is affected, discontinuation or changes in treatment may be necessary.

Eltrombopag may cause an increased risk of thrombosis. This side effect is also seen in female patients, especially those with underlying risk factors for blood clots, such as smoking, obesity or a family history of blood clots. During medication, women should not only pay attention to changes in platelet count, but also be alert to signs of thrombosis such as swelling and pain in the lower limbs. Once relevant symptoms appear, seek medical treatment immediately.

Another common side effect is gastrointestinal reactions, which include nausea, vomiting, diarrhea, etc. These reactions are also more common in female patients, especially in some drug-sensitive individuals. In order to relieve these discomforts, female patients can choose to take the medicine after meals, or consult a doctor to get a treatment plan that suits them.

In addition, eltrombopag may affect fertility. Although there is a lack of comprehensive research on the effects of eltrombopag on female fertility, if a woman is planning to become pregnant or is pregnant while taking this drug, it is important to discuss it with her doctor to assess potential risks and consider alternative treatments.

Reference materials:https://www.afwomensmed.com/health-library/hw-view.php?DOCHWID=a609011